Cargando…
Medical Machiavellianism: the tradeoff between benefit and harm with targeted chemotherapy
Machiavellianism is a word synonymous with the phrase “the end justifies the means”, and in this article we have coined the term Medical Machiavellianism to describe the ‘cruel-to-be-kind’ administration of toxic chemotherapeutic agents in apparent violation of the precept first do no harm, while ac...
Autores principales: | Oronsky, Bryan, Carter, Corey, Scicinska, Anna, Oronsky, Arnold, Oronsky, Neil, Lybeck, Michelle, Scicinski, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891024/ https://www.ncbi.nlm.nih.gov/pubmed/26814434 http://dx.doi.org/10.18632/oncotarget.6984 |
Ejemplares similares
-
Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapies
por: Carter, Corey A., et al.
Publicado: (2016) -
No patient left behind: The promise of immune priming with epigenetic agents
por: Carter, Corey A., et al.
Publicado: (2017) -
The War on Cancer: A Military Perspective
por: Oronsky, Bryan, et al.
Publicado: (2015) -
Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man—PFS2: A Measure of Therapeutic Action-At-A-Distance
por: Oronsky, Bryan, et al.
Publicado: (2015) -
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
por: Oronsky, Bryan, et al.
Publicado: (2017)